NDC 68788-7729-01 - levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-7729
- Requested NDC
- 68788-7729-01
- Package NDCs from labels
- 68788-7729-3, 68788-7729-9, 68788-7729-1, 68788-7729-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-05-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| levothyroxine sodium - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2026-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-7729-1 | levothyroxine sodium | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 68788-7729-3 | levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 68788-7729-9 | levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-7729 | LEVOTHYROXINE SODIUM TABLET [PREFERRED PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 3 package rows | 20240518_645c52bb-c46e-426e-91d4-151aeac975a7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7729-1 | EA - Each | 68788-7729 | 81e61844-ab0d-440c-83ef-d372cb16c471 | 1 | 2020-09-14 |
| 68788-7729-3 | EA - Each | 68788-7729 | 0b5d0988-46b9-4f7d-942f-52203bcb8304 | 1 | 2020-09-14 |
| 68788-7729-9 | EA - Each | 68788-7729 | 5ef99a29-47b0-43cd-8bd7-a2358628d880 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Cardinal Health 107, LLC | 31a31756-68aa-4e01-bbb1-9d181f8d9181 | 2026-09-18 | Boxed warning, Warnings, Adverse reactions | 966222 892246 966221 966224 966220 966225 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b45189d2-529b-4d5a-89a9-697bcd61fdb4 | 2026-09-17 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 5ae839f4-bca9-4601-ba80-f2018b9142e4 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | e9a9b3c8-2ebf-422f-a60b-8d2bd806f3f6 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1cacd07a-6fcc-4cdb-aee8-7a62493eb579 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 0266d5d9-edb3-4d0d-ab24-5d1d65f7e501 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2622a029-5f4f-4675-9e3d-66e7aa12ce9d | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Alvogen, Inc. | 4ddcaec1-a58f-340b-9bc1-bbe048b8c885 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | NDA021116 47781-651 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 3b8c38aa-ac99-1c0d-42f3-4fe8881125dc 4ddcaec1-a58f-340b-9bc1-bbe048b8c885 9J765S329G |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6f4bc4be-17a7-4273-a8d9-a1ff036dea0e | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 9ad82faf-3734-42a1-befe-f6197b27f534 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 817656c7-3b6d-4f94-83e6-dec9e0d35c84 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | bc9385d0-5c67-4bde-94da-e621347e2cba | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 4c903249-69e9-4168-a9d1-22e6c2c1eb22 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6f25cbb3-0358-4778-b8f0-f76479a2dcc5 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 7fd988be-ab3d-406d-a55d-1e5a8a2101cc | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6108759a-783e-42ca-b078-6a3cd84ce901 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 13e03769-9a4f-497f-9afa-95bf525090b3 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.